Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clear Pathway: the role of bempedoic acid in lipid-lowering strategies. The opinion of cardiologists from Piedmont and Aosta Valley, Italy].

Giornale italiano di cardiologia (2006)·2026
Same author

Laterocervical Lymph Node Metastases in Papillary Thyroid Carcinoma: Predictive Factors for Recurrence and Oncological Outcome.

Journal of personalized medicine·2025
Same author

Arrhythmogenic Right Ventricular Cardiomyopathy and Cor Triatriatum Dexter: An Unreported Association.

Clinical case reports·2025
Same author

Liquid biopsy in head and neck cancer patients: blood, saliva, or both ?

Precision clinical medicine·2025
Same author

[The modified hugging balloon technique].

Giornale italiano di cardiologia (2006)·2024
Same author

Bone-conduction Hearing Aids: A Scoping Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2024
Same journal

Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease.

Journal of interventional cardiology·2024
Same journal

Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.

Journal of interventional cardiology·2024
Same journal

Examining the Outcomes of Hybrid Coronary Revascularization in Acute STEMI Patients from 2015 to 2022.

Journal of interventional cardiology·2024
Same journal

Clinical and Laboratory Predictors of Long-Term Outcomes after Catheter Ablation for a Ventricular Electrical Storm.

Journal of interventional cardiology·2024
Same journal

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.

Journal of interventional cardiology·2024
Same journal

Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends.

Journal of interventional cardiology·2023
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

4D Printed Bifurcated Stents with Kirigami-Inspired Structures
06:52

4D Printed Bifurcated Stents with Kirigami-Inspired Structures

Published on: July 25, 2019

Update on dedicated bifurcation stents.

Imad Sheiban1, Pierluigi Omedé, Giuseppe Biondi-Zoccai

  • 1From the Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy. isheiban@yahoo.com

Journal of Interventional Cardiology
|April 22, 2009
PubMed
Summary
This summary is machine-generated.

Coronary bifurcation stenting remains challenging, with dedicated stents emerging to improve side-branch access and outcomes. Further research is needed to confirm the clinical efficacy and safety of these novel devices.

More Related Videos

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

4D Printed Bifurcated Stents with Kirigami-Inspired Structures
06:52

4D Printed Bifurcated Stents with Kirigami-Inspired Structures

Published on: July 25, 2019

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Devices
  • Biomedical Engineering

Background:

  • Coronary bifurcation lesions pose significant challenges in interventional cardiology.
  • While drug-eluting stents reduce main vessel restenosis, side-branch ostium issues persist.
  • Existing two-stent strategies have limitations, making the provisional approach the current default.

Purpose of the Study:

  • To review the challenges and advancements in treating coronary bifurcation lesions.
  • To discuss the role and potential of dedicated bifurcation stents.
  • To evaluate the future implications of new devices and drug-eluting platforms.

Main Methods:

  • Review of contemporary studies and randomized trials on coronary bifurcation stenting.
  • Analysis of various two-stent strategies (T-stenting, culotte, crush, etc.).
  • Examination of the design principles and intended benefits of dedicated bifurcation stents.

Main Results:

  • The provisional stenting approach is the current standard for most bifurcation lesions.
  • Dedicated bifurcation stents aim to simplify side-branch access and treatment.
  • Eleven new bifurcation stent devices are in early clinical trial phases.

Conclusions:

  • Dedicated bifurcation stents show promise for improving percutaneous coronary intervention outcomes.
  • These devices may facilitate simultaneous main and side-branch treatment.
  • Larger studies are required to validate the clinical applicability, efficacy, and safety of dedicated bifurcation stents before widespread adoption.